Changcheng Zhou

机构：University of California, Riverside, China Southern Power Grid (China) · ORCID：0000-0001-7649-0710

发表论文 142 篇 · 总被引 4852 次 · h-index 35

代表论文

• OA03.04 A Phase 1b Study Of Furmonertinib, an Oral, Brain Penetrant, Selective EGFR Inhibitor, in Patients with Advanced NSCLC with EGFR Exon 20 Insertions (2023 · Journal of Thoracic Oncology · 被引 49)
• Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting (2024 · Journal of Controlled Release · 被引 24)
• Paternal hypercholesterolemia elicits sex-specific exacerbation of atherosclerosis in offspring (2024 · JCI Insight · 被引 18)
• Ubiquitin-specific peptidase 25 exacerbated osteoarthritis progression through facilitating TXNIP ubiquitination and NLRP3 inflammasome activation (2023 · Journal of Orthopaedic Surgery and Research · 被引 14)
• Platelet-derived thrombospondin 1 promotes immune cell liver infiltration and exacerbates diet-induced steatohepatitis (2024 · JHEP Reports · 被引 12)
• Construction of tissue-engineered bladders using an artificial acellular nanocomposite scaffold loaded with stromal vascular fraction secretome (2023 · Acta Biomaterialia · 被引 11)